Evox Therapeutics Limited
Evox Therapeutics is dedicated to developing transformative exosome therapeutics aimed at treating serious, life-threatening rare diseases. Their innovative DeliverEX™ platform combines advanced biomolecular engineering with exosome delivery technology to create effective treatment options for patients with limited alternatives.
Founded: 22 Mar 2016
Industries:
72110 - Research and experimental development on biotechnology
Website: evoxtherapeutics.com
Phone: 00441865819140
Location: Oxford
Products & Services
• biomolecular engineering
• deliverex™ platform
• exosome-based therapeutics development
• exosome-delivered aav gene therapy
• exosome therapeutics
• gene therapy
• rare diseases
• research institute
Financial Snapshot
Cash in Bank
Turnover
EBITDA
Gross Profit
Total Liabilities
Employees
Unlock financial data with Pro Start Free Trial →
People
Officers
6
Shareholders
45
Controllers (PSC)
1
Per Lundin
Director • Swedish • Lives in United Kingdom • Born in Apr 1983
Martin Andrews
Director • British • Lives in United Kingdom • Born in Jul 1963
Evan Samuel Caplan
Director • American • Lives in United States • Born in Dec 1988
Wallace Lucy Elizabeth Wallace
Director • British • Lives in United Kingdom • Born in May 1989
Laura Ann Taylor Feinleib
Director • American • Lives in United States • Born in Nov 1995
Registered Office Address
Medawar Centre 2nd Floor East Building
Robert Robinson Avenue
Oxford
OX4 4HG
United Kingdom
Basic Information
LTD
22 Mar 2016
ENGLAND WALES
Yes
Industry Classification
72110
Company Attributes
N/A
N/A
N/A
N/A
Summary
17
Officers
1
PSCs
0
Filings